Internet Stroke Center Home Stroke Trials Registry
 
National Institute of Neurological Disorders & Stroke
American Stroke Association
Washington University School of Medicine
 
Trials Directories
Ongoing Trials
Completed Trials
Acute Stroke Trials
Hemorrhage Trials
Prevention Trials
Recovery Trials
Interventions
Drugs - By Name
Drugs - By Category
Procedures
Recovery Therapies
Assessment Scales
Specific Stroke Scales
Stroke Scales Overview
Stroke Trial Links
Government Sites
Independent Sites
News & Updates
Update List
General Stroke News
About this Site
Submit Your Trial
Send Feedback
Search for Trials
PubMed
We comply with the "Health on the Net" (HON) code of standards for trustworthy health information: verify here.



 
Stroke Interventions in Clinical Trials
Printable Version
Tenecteplase
TNKase

Action
Intravenous thrombolytic agent. Bioengineered plasminogen activator, similar to tissue plasminogen activator.

Status
Approved 6/2000 by the U.S. Food and Drug Administration for the treatment of acute myocardial infarction (AMI). US stroke trials announced 9/2000.

Trial(s)
  = Ongoing
  = Completed

Study of Tenecteplase (TNK) in Acute Ischemic Stroke (TNK-S2B)[SPOTRIAS]
TNK in Acute Ischemic Stroke [SPOTRIAS]
TNKilas Tenecteplase For Ischemic Lacunar Stroke

Web Links and Publications

UID: 129

   

Internet Stroke Center at Washington University:
HOME | ABOUT | PRIVACY POLICY | CONTACT

Copyright © 1997-2009 - Internet Stroke Center. All rights reserved.                                           Last modified: Friday, November 20, 2009